Faruqi & Faruqi, LLP is Investigating Keryx Biopharmaceuticals, Inc. (KERX) on Behalf of its Shareholders
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential wrongdoing at Keryx Biopharmaceuticals, Inc. ("Keryx " or the "Company") (Nasdaq: KERX).
If you currently own Keryx stock and have continuously owned Keryx stock and would like to discuss your legal rights, please visit www.faruqilaw.com/KERX. You can also contact us by calling Nadeem Faruqi toll free at (212) 983-9330 or by sending an e-mail to email@example.com. Faruqi & Faruqi, LLP also encourages anyone with information regarding Keryx’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
Faruqi & Faruqi, LLP
685 Third Avenue 26th Floor
New York, NY 10017
Tel: (212) 983-9330
If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.